Three experts recently gathered to discuss how ATMP developers weathered the pandemic and the potential implications on quality control.
The Pandemic’s Impact on Pharmaceutical Quality Control: An Expert Discussion
ATMPs Overcoming Development Challenges to Address Previously Untreatable Diseases
The ATMP landscape has been growing at a rapid rate since 2017, a momentous year in which three cell and gene therapies were approved—all the first of their kind.
Exploring Sepsis & AKI: Interview with Dr. Alexander Flannery
By the bioMérieux Connection Editors In a recent interview with Dr. Alexander Flannery, a Critical Care Pharmacist at the University of Kentucky HealthCare, we had the opportunity to discuss his team’s research on sepsis-associated acute kidney disease (AKD)—a term that Dr. Flannery uses to refer to “a non-resolving acute kidney injury (AKI) that lasts at …
Continue reading “Exploring Sepsis & AKI: Interview with Dr. Alexander Flannery”
An Introduction to ATMPs: A Paradigm Shift in Healthcare
Parkinson’s Disease. Diabetes. Muscular dystrophy. These diseases all lack cures, but they also share another important similarity: the quest for their cures is playing out in the field of ATMPs.
The Value of Diagnostics in Combatting Antimicrobial Resistance – A Public Health Problem
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
Lindsay Denny Discusses the Critical Role of WASH in Preventing Infectious Diseases and Fighting Antimicrobial Resistance
WASH, which stands for water, sanitation, and hygiene, are basic...